Advertisement
Screener

Jade Biosciences, Inc. (JBIO) ROE

Jade Biosciences, Inc. (JBIO) ROE

  • 2026-06-30: ROE -34.83%.
  • 2026-03-31: ROE -43.72%.
  • 2025-12-31: ROE -38.32%.
  • 2025-09-30: ROE -56.26%.

Complete source-backed roe history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical ROE

DateROE
2026-06-30-34.83%
2026-03-31-43.72%
2025-12-31-38.32%
2025-09-30-56.26%
2025-06-30-45.94%
2025-03-31102.07%
2024-12-31150.13%
2024-09-30505.49%
2024-06-3014929.88%
2024-03-31-90.41%
2023-12-31-69.00%
2023-09-30-55.78%
2023-06-30-45.20%
2023-03-31-50.51%
2022-12-31-40.64%
2022-09-30-32.14%
2022-06-30-24.70%
2022-03-31-19.20%
2021-12-31-13.32%
2021-09-30-10.23%
2021-06-3067.33%
2021-03-3167.99%
2020-12-3172.02%

Annual ROE

DateROE
2025-12-31-38.32%
2024-12-31148.78%
2023-12-31-69.00%
2022-12-31-40.64%
2021-12-31-13.32%
2020-12-3172.02%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Arbutus Biopharma Corp (ABUS)$0.965B6.19
Kura Oncology, Inc. (KURA)United States$0.967B-3.29
Apnimed, Inc. (APMD)United States$0.899B
RIGEL PHARMACEUTICALS INC (RIGL)United States$0.893B2.25
Theravance Biopharma, Inc. (TBPH)$0.885B16.40
Cryoport, Inc. (CYRX)United States$0.881B-21.29
Corvus Pharmaceuticals, Inc. (CRVS)United States$0.994B-23.25
ARDELYX, INC. (ARDX)United States$0.857B-22.86
Janux Therapeutics, Inc. (JANX)United States$1.019B-9.15
Pacira BioSciences, Inc. (PCRX)United States$1.020B69.03